Next Article in Journal
Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
Next Article in Special Issue
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
Previous Article in Journal
Pri-miR526b and Pri-miR655 Are Potential Blood Biomarkers for Breast Cancer
Previous Article in Special Issue
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
 
 
Review

Article Versions Notes

Cancers 2021, 13(15), 3840; https://doi.org/10.3390/cancers13153840
Action Date Notes Link
article xml file uploaded 30 July 2021 11:46 CEST Original file -
article xml uploaded. 30 July 2021 11:46 CEST Update https://www.mdpi.com/2072-6694/13/15/3840/xml
article pdf uploaded. 30 July 2021 11:46 CEST Version of Record https://www.mdpi.com/2072-6694/13/15/3840/pdf
article html file updated 30 July 2021 11:47 CEST Original file -
article html file updated 27 July 2022 07:23 CEST Update https://www.mdpi.com/2072-6694/13/15/3840/html
Back to TopTop